Russian Federation: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in the Russian Federation

The Russian prophylactic medicaments containing insulin market expanded slightly to $X in 2022, picking up by X% against the previous year. The market value increased at an average annual rate of X% from 2012 to 2022; however, the trend pattern remained relatively stable, with somewhat noticeable fluctuations being recorded in certain years. Over the period under review, the market hit record highs at $X in 2015; however, from 2016 to 2022, consumption remained at a lower figure.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in the Russian Federation

In value terms, prophylactic medicaments containing insulin production stood at $X in 2022 estimated in export price. The total output value increased at an average annual rate of X% over the period from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. The pace of growth appeared the most rapid in 2020 with an increase of X% against the previous year. Over the period under review, production attained the peak level at $X in 2015; however, from 2016 to 2022, production stood at a somewhat lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from the Russian Federation

In 2022, the amount of medicaments containing insulin but not antibiotics in measured doses exported from Russia shrank notably to X tons, with a decrease of X% on the previous year's figure. Overall, exports, however, recorded significant growth. The most prominent rate of growth was recorded in 2020 with an increase of X%. The exports peaked at X tons in 2018; however, from 2019 to 2022, the exports failed to regain momentum.

In value terms, prophylactic medicaments containing insulin exports dropped markedly to $X in 2022. In general, exports, however, recorded a significant increase. The most prominent rate of growth was recorded in 2020 with an increase of X%. As a result, the exports attained the peak of $X. From 2021 to 2022, the growth of the exports remained at a somewhat lower figure.

Exports by Country

Azerbaijan (X tons) was the main destination for prophylactic medicaments containing insulin exports from Russia, with a X% share of total exports. Moreover, prophylactic medicaments containing insulin exports to Azerbaijan exceeded the volume sent to the second major destination, Uzbekistan (X kg), ninefold. Switzerland (X kg) ranked third in terms of total exports with an X% share.

From 2012 to 2022, the average annual growth rate of volume to Azerbaijan was relatively modest. Exports to the other major destinations recorded the following average annual rates of exports growth: Uzbekistan (X% per year) and Switzerland (X% per year).

In value terms, Azerbaijan ($X) emerged as the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from Russia, comprising X% of total exports. The second position in the ranking was taken by Uzbekistan ($X), with an X% share of total exports. It was followed by Switzerland, with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of value to Azerbaijan was relatively modest. Exports to the other major destinations recorded the following average annual rates of exports growth: Uzbekistan (X% per year) and Switzerland (X% per year).

Export Prices by Country

The average prophylactic medicaments containing insulin export price stood at $X per ton in 2022, with an increase of X% against the previous year. In general, the export price saw a remarkable increase. The pace of growth appeared the most rapid in 2017 an increase of X%. Over the period under review, the average export prices reached the maximum at $X per ton in 2020; however, from 2021 to 2022, the export prices stood at a somewhat lower figure.

There were significant differences in the average prices for the major foreign markets. In 2022, amid the top suppliers, the country with the highest price was China ($X per ton), while the average price for exports to Switzerland ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Switzerland (X%).

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into the Russian Federation

In 2022, purchases abroad of medicaments containing insulin but not antibiotics in measured doses decreased by X% to X tons, falling for the seventh consecutive year after four years of growth. Overall, imports, however, saw mild growth. The growth pace was the most rapid in 2013 when imports increased by X% against the previous year. Imports peaked at X tons in 2015; however, from 2016 to 2022, imports remained at a lower figure.

In value terms, prophylactic medicaments containing insulin imports rose markedly to $X in 2022. Over the period under review, imports continue to indicate a deep reduction. The growth pace was the most rapid in 2013 with an increase of X%. As a result, imports reached the peak of $X. From 2014 to 2022, the growth of imports remained at a somewhat lower figure.

Imports by Country

Germany (X tons), France (X tons) and India (X tons) were the main suppliers of prophylactic medicaments containing insulin imports to Russia, together accounting for X% of total imports.

From 2012 to 2022, the biggest increases were recorded for Germany (with a CAGR of X%), while purchases for the other leaders experienced a decline.

In value terms, Germany ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics in measured doses to Russia, comprising X% of total imports. The second position in the ranking was held by France ($X), with a X% share of total imports.

From 2012 to 2022, the average annual rate of growth in terms of value from Germany stood at X%. The remaining supplying countries recorded the following average annual rates of imports growth: France (X% per year) and India (X% per year).

Import Prices by Country

The average prophylactic medicaments containing insulin import price stood at $X per ton in 2022, with an increase of X% against the previous year. Overall, the import price, however, continues to indicate a abrupt setback. The import price peaked at $X per ton in 2012; however, from 2013 to 2022, import prices remained at a lower figure.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Germany ($X per ton), while the price for France ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by India (X%), while the prices for the other major suppliers experienced a decline.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :